Drugs / L-Vax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00298298 | Jan 2006 → Jan 2014 | non-small cell lung carcinoma | AVAX Technologies | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-Vax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00298298 ↗ |
| Modality | Vaccine | “DNP-modified autologous NSCLC cell vaccine” NCT00298298 ↗ |